P-Glitz Tablet (Pioglitazone) | For Type 2 Diabetes Mellitus Management, Insulin Sensitization Improvement

Rating:

80% of 100

P-Glitz Tablet is an antidiabetic medicine belonging to the thiazolidinedione group. It helps manage blood sugar levels in adults with type 2 diabetes by improving the body's sensitivity to insulin.

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Product Overview

What Is P-Glitz Tablet?

P-Glitz Tablet contains pioglitazone as its active ingredient, subject to confirmation from the product packaging. Pioglitazone belongs to a group of medicines called thiazolidinediones. It helps manage blood glucose levels in adults with type 2 diabetes by improving the body's sensitivity to insulin.

Insulin is a hormone that helps move glucose from the bloodstream into the body's cells, where it can be used for energy. When the body does not respond effectively to insulin, glucose levels can remain elevated. Pioglitazone helps address this reduced insulin sensitivity.

How Does P-Glitz Tablet Work?

P-Glitz Tablet works by improving the way muscle, fat, and liver cells respond to insulin. Its active ingredient, pioglitazone, activates specific receptors involved in glucose and fat metabolism.

This action helps the body use insulin more effectively and supports better blood glucose control. Unlike some diabetes medicines, pioglitazone does not primarily work by stimulating the pancreas to release more insulin.

Benefits of Improving Insulin Sensitivity

Improving insulin sensitivity can help the body regulate glucose more effectively. Pioglitazone works gradually, and its full blood glucose-lowering effect may take several weeks to develop.

The medicine may be used as a single agent or in combination with other diabetes treatments when considered appropriate. The choice depends on factors such as blood glucose levels, existing treatment, and individual clinical needs.

How Is P-Glitz Tablet Taken?

P-Glitz Tablet is taken by mouth according to the directions provided by a healthcare professional. Pioglitazone tablets can generally be taken with or without food. The recommended strength, timing, and duration depend on the individual's treatment plan.

Taking the tablet consistently as directed helps maintain a regular treatment routine. Do not change the dose independently.

Available Strengths and Composition

Pioglitazone tablets are commonly available in strengths such as 15 mg, 30 mg, and 45 mg. However, the exact strengths available under the P-Glitz brand should be confirmed from the manufacturer's packaging.

Product detail	Information
Brand	P-Glitz Tablet
Active ingredient	Pioglitazone, subject to pack verification
Medicine category	Thiazolidinedione
Dosage form	Oral tablet
Common pioglitazone strengths	15 mg, 30 mg, and 45 mg, depending on the product
Main treatment area	Type 2 diabetes management

Precaution

P-Glitz Tablet may contain pioglitazone, a medicine used to manage blood sugar levels in adults with type 2 diabetes. Confirm the active ingredient and strength on the product packaging before use.

1. Heart Health

Inform your healthcare professional about any history of heart problems, as pioglitazone can cause fluid retention and may worsen heart failure.

2. Liver Function

Liver function may need to be checked before and during treatment. Report unusual tiredness, dark urine, or yellowing of the skin or eyes.

3. Blood Sugar Monitoring

Monitor blood glucose regularly, especially if P-Glitz is taken with other diabetes medicines.

4. Fluid Retention

Watch for unusual swelling of the feet or ankles, sudden weight gain, or difficulty breathing. Seek prompt medical assessment if these occur.

5. Pregnancy and Breastfeeding

Consult a healthcare professional before using pioglitazone during pregnancy or breastfeeding to assess whether it is suitable.

6. Bone Health

Pioglitazone may increase the risk of bone fractures, particularly with long-term use. Discuss any history of fractures or bone problems before starting treatment.

Usage

P-Glitz Tablet may contain pioglitazone, a thiazolidinedione medicine used to help manage blood sugar levels in adults with type 2 diabetes. Confirm the active ingredient and strength on the product packaging before use.

How to Take P-Glitz Tablet

Follow instructions: Take the tablet according to your healthcare professional's directions.
With or without food: Pioglitazone can generally be taken with or without food.
Maintain a routine: Take it consistently at the recommended time each day.
Swallow with water: Follow the instructions supplied with the specific product.
Missed dose: Follow the patient leaflet's guidance. Do not take a double dose to make up for a missed one.

Uses

P-Glitz Tablet may contain pioglitazone as its active ingredient. It belongs to the thiazolidinedione group of medicines and helps manage blood sugar levels in adults with type 2 diabetes by improving the body's sensitivity to insulin. Confirm the composition on the product packaging before use.

1. Management of Type 2 Diabetes

P-Glitz helps improve insulin sensitivity, allowing the body to use glucose more effectively and supporting blood sugar control.

2. Improving Insulin Response

Pioglitazone helps muscle, fat, and liver cells respond better to insulin, supporting the body's natural glucose-regulation process.

3. Long-Term Blood Sugar Control

When used as part of an appropriate treatment plan, pioglitazone can help maintain better blood glucose levels over time.

4. Support Alongside Lifestyle Changes

P-Glitz may be used alongside balanced nutrition and regular physical activity to support type 2 diabetes management.

Side Effects

P-Glitz Tablet may contain pioglitazone as its active ingredient, a medicine used to manage blood sugar levels in adults with type 2 diabetes. Confirm the product's composition on the packaging, as side effects may differ for combination formulations.

Common Effects

1. Weight Gain

Pioglitazone may cause weight gain during treatment. Unusual or rapid weight gain should be discussed with a healthcare professional.

2. Swelling

Swelling of the feet, ankles, or legs may occur due to fluid retention.

3. Headache

Some people may experience headaches while taking pioglitazone.

4. Muscle Pain

Muscle aches or discomfort may occur in some individuals during treatment.

5. Low Blood Sugar

Low blood sugar may occur, particularly when pioglitazone is taken with insulin or certain other diabetes medicines.

6. Vision Changes

Blurred vision or other changes in eyesight may occur and should be assessed if persistent.

FAQs

1. What is P-Glitz Tablet used for?

P-Glitz Tablet may contain pioglitazone, which helps manage blood sugar levels in adults with type 2 diabetes.

2. What is the active ingredient in P-Glitz Tablet?

The active ingredient is pioglitazone in the single-ingredient formulation. Check the product packaging to confirm.

3. How does P-Glitz Tablet work?

It improves the body's sensitivity to insulin, helping cells use glucose more effectively.

4. How should P-Glitz Tablet be taken?

Take it according to your healthcare professional's instructions. Pioglitazone can generally be taken with or without food.

5. Can P-Glitz Tablet be taken with other diabetes medicines?

Yes, it may be combined with certain diabetes medicines when appropriate. Monitoring may be needed to manage the risk of low blood sugar.

6. How long does P-Glitz Tablet take to work?

Pioglitazone works gradually, and its full blood sugar-lowering effect may take several weeks.

7. Does P-Glitz Tablet require regular monitoring?

Yes, blood glucose levels and liver function may need monitoring during treatment.

8. Can P-Glitz Tablet cause weight gain?

Weight gain may occur with pioglitazone. Unusual weight gain with swelling or breathing difficulties requires prompt medical assessment.

Interactions

P-Glitz Tablet may contain pioglitazone, a medicine used to manage blood sugar levels in adults with type 2 diabetes. Confirm the active ingredient on the product packaging, as interactions may vary with combination formulations.

1. Insulin

Taking pioglitazone with insulin may increase the risk of fluid retention and heart failure. Medical monitoring may be required.

2. Other Diabetes Medicines

Medicines such as sulfonylureas may increase the risk of low blood sugar when combined with pioglitazone. Blood glucose monitoring may help identify changes.

3. Gemfibrozil

Gemfibrozil may increase pioglitazone levels in the body, potentially increasing its effects. A healthcare professional may need to adjust the treatment plan.

4. Rifampicin

Rifampicin may reduce pioglitazone levels and affect blood sugar control. Monitoring may be necessary when these medicines are used together.

5. Other Medicines Affecting Blood Sugar

Certain medicines, including corticosteroids, may raise blood glucose levels and affect diabetes management. Inform your healthcare professional about any new medicine.

6. Hormonal Contraceptives

Pioglitazone may affect the effectiveness of some hormonal contraceptives. Discuss suitable contraceptive options with a healthcare professional.